A remarkable response to combination chemotherapy with nivolumab and ipilimumab in a patient with primary pulmonary choriocarcinoma: a case report

BACKGROUND: Primary pulmonary choriocarcinoma (PPC) is a rare malignancy, and only 41 PPC cases have been reported in males up to 2021. Due to its rarity, no standardized treatments for PPC have been established. Cytotoxic chemotherapy has limited efficacy, and the prognosis of advanced PPC is notab...

Descripción completa

Detalles Bibliográficos
Autores principales: Iso, Hirokazu, Hisakane, Kakeru, Terashi, Naoki, Mikami, Erika, Matsuki, Satoru, Sonokawa, Takumi, Atsumi, Kenichiro, Yoshino, Naoyuki, Nagata, Kohji, Seike, Masahiro, Hirose, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493795/
https://www.ncbi.nlm.nih.gov/pubmed/37701113
http://dx.doi.org/10.21037/tcr-23-221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493795/
https://www.ncbi.nlm.nih.gov/pubmed/37701113
http://dx.doi.org/10.21037/tcr-23-221

Ejemplares similares